α 2A -Adrenergic Receptors in the Genetics, Pathogenesis, and Treatment of Type 2 Diabetes
- 23 December 2009
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 1 (12) , 12ps15
Abstract
Genetic variation of α 2A -adrenergic receptors on pancreatic β cells provides new avenues for diagnosis and treatment of type 2 diabetes.Keywords
This publication has 17 references indexed in Scilit:
- Overexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 DiabetesScience, 2010
- Pathomechanisms of Type 2 Diabetes GenesEndocrine Reviews, 2009
- Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?Acta Diabetologica, 2009
- Advances in Male ContraceptionEndocrine Reviews, 2008
- Identification of Novel Candidate Genes for Type 2 Diabetes From a Genome-Wide Association Scan in the Old Order AmishDiabetes, 2007
- Complex haplotypes derived from noncoding polymorphisms of the intronless α 2A -adrenergic gene diversify receptor expressionProceedings of the National Academy of Sciences, 2006
- The genetics of type 2 diabetesBest Practice & Research Clinical Endocrinology & Metabolism, 2001
- Four Consecutive Serines in the Third Intracellular Loop Are the Sites for β-Adrenergic Receptor Kinase-mediated Phosphorylation and Desensitization of the α2A-Adrenergic ReceptorJournal of Biological Chemistry, 1995
- Effect of an oral α2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitusMetabolism, 1991
- Induction of Defective Insulin Secretion and Impaired Glucose Tolerance by Clonidine Selective Stimulation of Metabolic Alpha-adrenergic PathwaysDiabetes, 1978